Paradigm Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Paradigm Asset Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-11,800	Closed	-$663K	–	549
2017 Q2	$663K	Sell	11,800 -12,200	-51%	-$489K	0.13%	167
2017 Q1	$941K	Buy	+24,000	New	+$764K	0.18%	124
2016 Q2	–	Sell	-18,200	Closed	-$371K	–	844
2016 Q1	$371K	Hold	18,200	–	–	0.07%	256
2015 Q4	$936K	Buy	+18,200	New	+$882K	0.16%	119
2015 Q1	–	Sell	-11,600	Closed	-$329K	–	864
2014 Q4	$329K	Sell	11,600 -800	-6%	-$22.2K	0.04%	422
2014 Q3	$313K	Sell	12,400 -40,100	-76%	-$1.06M	0.04%	410
2014 Q2	$1.53M	Buy	+52,500	New	+$1.27M	0.21%	150

Other funds holding PTLA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Paradigm Asset Management's PTLA Position: Q3 2017 in Review

Paradigm Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2017, closing a stake of 11,800 shares — an estimated $663K sold.

Paradigm Asset Management first reported a position in PTLA in Q2 2014 and held it in 7 quarters. The position peaked at $1.53M in Q2 2014. 221 funds tracked by Wall St. Rank hold PTLA as of Q3 2017.

Paradigm Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
Paradigm Asset Management sold 11,800 Portola Pharmaceuticals, Inc. shares in Q3 2017, an estimated $663K.
Paradigm Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2014 and held it in 7 quarters.
Paradigm Asset Management's Portola Pharmaceuticals, Inc. position peaked at $1.53M in Q2 2014.
221 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2017.

Based on Paradigm Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.